Randomized controlled trial to examine the influence to vascular endothelium function to treat of anemia in the heart disease patients with chronic kidney disease.

Randomized controlled trial to examine the influence to vascular endothelium function to treat of anemia in the heart disease patients with chronic kidney disease. - Impact on vascular endothelium function to treat of anemia in the heart disease patients with chronic kidney disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014497

Enrollment

Registered

2014-07-07

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart disease,Coronary artery disease, Chronic kidni disease, anemia

Interventions

epoetin beta pegol iron drug

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CKD eGFR<60 8<Hb<11 NYHA 2,3 stable coronary artery disease

Exclusion criteria

Exclusion criteria: HD Anemia without renal anemia Bleeding Malignancy Iron deficiency anemia

Design outcomes

Primary

Measure	Time frame
Vascular endotherium function	—

Countries

Japan

Contacts

Public ContactSeiji Hokimoto

Graduate School of Medical Sciences, Kumamoto University Department of Cardiovascular Medicine

shokimot@kumamoto-u.ac.jp096-373-5175

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026